WKL Wolters Kluwer NV

Business Insider Report Lists Wolters Kluwer Among Healthcare Artificial Intelligence Leaders Targeting Physician Burnout

A new digital health research report from Business Insider Intelligence investigates physician burnout, which has increased dramatically in 2020, fueled by the stress of caring for patients with coronavirus. According to the report, “,” the issue of fatigue impacted 40% of U.S. physicians before COVID-19 and costs U.S. healthcare organizations $4.6 billion per year. As providers look for ways to reduce burnout and cut related costs, many are turning to leaders in healthcare AI technology like , which has widespread experience in anticipating and supporting clinicians’ needs and workflows to speed clinical decision making and ease administrative loads.

This report identified several startups and big tech companies developing AI-based healthcare administration solutions with machine learning and natural language processing that are starting to take hold. These advances in clinical workflow automation and clinical documentation are helping clinicians spend more time caring for patients.

Wolters Kluwer: What’s Next

In the forward-looking “What’s Next” segment of the report, Wolters Kluwer is cited as a key resource being leveraged to . The report found, Wolters Kluwer’s clinical decision support resource expedites “clinicians’ access to evidence-based medical information via advanced voice search capabilities. The new efficiencies afforded by the platform's improved information search function are able to generate significant time savings for physicians while improving the quality of their care.”

“We are driven to innovate with AI, helping health organizations tackle health data challenges and supporting clinicians’ care for their patients,” commented , Wolters Kluwer, Health. “The Business Insider report affirms our commitment to developing partnerships with other healthcare technology leaders to boost the roles of AI and voice in making a meaningful impact on healthcare.”

Leadership in AI in Healthcare

Wolters Kluwer is coupling the expansive knowledge of its trusted clinical experts with impactful AI solutions that target complex problems in healthcare. A recent Frost & Sullivan Radar report, “Artificial Intelligence for Healthcare IT, Global, 2020” also ranked . The upper-right quadrant position of Wolters Kluwer, adjacent to well-recognized tech giants, underscores its superior deep learning and NLP capabilities.

Indicators of this AI innovation in Health solutions include:

  • Adaptive learning for next-generation doctors and nurses: Tomorrow’s clinicians get a strong start in medical and nursing education with adaptive learning powered by AI that optimizes student testing skills, remediation and performance in high-stakes USMLE or NCLEX exams with ® and ®.
  • Earlier intervention when it matters most: Minutes can be the difference between life and death for patients with hospital-acquired infections (HAIs) like sepsis or C. difficile. AI technology in ® and is so patients get every fighting chance.
  • Unlocking hidden insights: Critical patient information lost in physician notes is extracted and mapped by for better informed care and AI is eliminating .
  • Globalizing drug data: AI is being developed to dramatically accelerate and automate the mapping of highly variable drug data from countries around the world to to reduce medication errors, adverse drug events and unnecessary alerts.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
29/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details December 11 – December 17, 2025

Share Buyback Transaction Details December 11 – December 17, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 11 – December 17, 2025 Alphen aan den Rijn – December 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 238,453 of its own ordinary shares in the period from December 11, 2025, up to and including December 17, 2025, for €21.4 million and at an average share price of €89.85. These repurchases are part of the share buyback...

 PRESS RELEASE

Share Buyback Transaction Details December 4 – December 10, 2025

Share Buyback Transaction Details December 4 – December 10, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 4 – December 10, 2025 Alphen aan den Rijn – December 11, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 209,603 of its own ordinary shares in the period from December 4, 2025, up to and including December 10, 2025, for €18.7 million and at an average share price of €89.33. These repurchases are part of the share buyback pr...

David Vagman ... (+5)
  • David Vagman
  • CFA
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Wolters Kluwer/AI winner at an attractive valuation/BUY

Our conviction in the Wolters Kluwer investment case remains high. Three positives stand out in our view. Firstly, current trading is solid, with 9M25 organic revenue growth beating expectations. Secondly, the company's expert curated (proprietary) content is a strong moat vs AI-only alternatives as the company operates in high-stake environments where reliability is key. Thirdly, valuation has become highly attractive. We slightly lower our target price to €160 per share (from €173). We keep ou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch